Assessment of the activity of the immune system in patients with inflammatory bowel diseases and asymptomatic COVID-19

Assessment of the activity of the immune system in patients with inflammatory bowel diseases and asymptomatic COVID-19

Saved in:

Bibliographic Details
Main Authors:	Michał Łodyga, Katarzyna Maciejewska, Kamila Stawczyk-Eder, Piotr Eder, Agnieszka Dobrowolska, Maria Wiśniewska-Jarosińska, Anita Gąsiorowska, Małgorzata Cicha, Grażyna Rydzewska
Format:	Article
Language:	English
Published:	Termedia Publishing House 2023-01-01
Series:	Gastroenterology Review
Subjects:	covid-19 inflammatory bowel disease cytokines.
Online Access:	https://www.termedia.pl/Assessment-of-the-activity-of-the-immune-system-in-patients-with-inflammatory-bowel-diseases-and-asymptomatic-COVID-19,41,49971,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The introduction of the IBD Disk in Poland – a new tool for assessing disability in patients with inflammatory bowel disease
by: Piotr Eder, et al.
Published: (2019-05-01)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
by: Magdalena Kaniewska, et al.
Published: (2019-12-01)

Inflammatory bowel diseases and the clinical course of coronavirus disease 2019 – a Polish single-centre experience from the pre-vaccine era
by: Estera Banasik, et al.
Published: (2023-12-01)

Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases
by: Piotr Eder, et al.
Published: (2021-02-01)

The position statement of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic
by: Michał Łodyga, et al.
Published: (2020-04-01)

Assessment of sexual dysfunction in patients with inflammatory bowel disease
by: Dorota Szydlarska, et al.
Published: (2019-07-01)

The relationship between the symptom of fatigue and the functioning of patients with inflammatory bowel diseases after surgery
by: Grażyna Bączyk, et al.
Published: (2019-12-01)

Management of anemia in inflammatory bowel disease: a challenge in everyday clinical practice
by: Edyta Tulewicz-Marti, et al.
Published: (2017-12-01)

SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients – does treatment for IBD negatively affect SARS-CoV-2 antibodies? A single-centre, prospective study
by: Katarzyna Karłowicz, et al.
Published: (2023-07-01)

Butyric acid – a well-known molecule revisited
by: Katarzyna Borycka-Kiciak, et al.
Published: (2017-06-01)

Analysis of risk factors of Clostridioides difficile infection in patients with inflammatory bowel disease
by: Alicja Jakubowska, et al.
Published: (2024-09-01)

Ophthalmological manifestations in inflammatory bowel disease under the watchful eye of a gastroenterologist from a tertiary centre
by: Konrad Lewandowski, et al.
Published: (2024-11-01)

The risk of small bowel adenocarcinoma in patients with Crohn’s disease
by: Gustaw Lech, et al.
Published: (2020-12-01)

Health-related quality of life assessment among patients with inflammatory bowel diseases after surgery – review
by: Grażyna Bączyk, et al.
Published: (2016-11-01)

Does faecal calprotectin differentiate between inflammatory bowel disease colitis and non-inflammatory bowel disease colitides?
by: Ahmed F. Khalil, et al.
Published: (2020-11-01)

Inflammatory Bowel Diseases and Irritable Bowel Syndrome: Overlap of Two Nosological Forms or Two Variants of the Same Disease?
by: A. A. Sheptulin, et al.
Published: (2019-12-01)

Translation and validation of the inflammatory bowel disease fatigue (IBD-F) patient self-assessment questionnaire
by: Ariel Liebert, et al.
Published: (2021-06-01)

Sexual functions in individuals with inflammatory bowel diseases
by: Marta Kotkowicz-Szczur, et al.
Published: (2023-03-01)

The role of adhesion molecules in inflammatory bowel disease in children. Assessment of the possible risk of cardiovascular complications
by: Aneta Trzeciak-Jędrzejczyk, et al.
Published: (2017-09-01)

Management of anaemia in patients with inflammatory bowel disease – results of a questionnaire among Polish healthcare professionals
by: Edyta M. Tulewicz-Marti, et al.
Published: (2021-03-01)

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
by: Konrad Lewandowski, et al.
Published: (2022-01-01)

Inflammatory bowel diseases during the COVID-19 pandemic
by: Edyta Derda, et al.
Published: (2024-09-01)

The efficacy and safety of the biosimilar product (Inflectra®) compared to the reference drug (Remicade®) in rescue therapy in adult patients with ulcerative colitis
by: Magdalena Kaniewska, et al.
Published: (2017-09-01)

Use of functional magnetic resonance imaging in patients with irritable bowel syndrome and functional dyspepsia
by: Katarzyna Skrobisz, et al.
Published: (2019-09-01)

Factors affecting perception and acceptance of colonoscopy in patients with inflammatory bowel disease
by: Chang-Hung Liao, et al.
Published: (2025-01-01)

Inflammatory bowel disease – one entity with many molecular faces
by: Sylwia Szymańska, et al.
Published: (2019-12-01)

Immunopathogenesis of inflammatory bowel diseases
by: Ye. A. Konovich, et al.
Published: (2013-09-01)

Immunosuppressants in modern approaches to treatment of inflammatory bowel diseases
by: O. B. Schukina, et al.
Published: (2013-05-01)

The Role and the Regulation of NLRP3 Inflammasome in Irritable Bowel Syndrome: A Narrative Review
by: Arezina Kasti, et al.
Published: (2025-01-01)

The effects of hyperbaric treatment on perianal fistula activity in patients with Crohn’s disease
by: Grażyna Piotrowicz, et al.
Published: (2024-09-01)

Frequency and Risk Factors of Advanced Neoplasia in Korean Inflammatory Bowel Disease Patients with Low-grade Dysplasia
by: Kyeong Ok Kim, et al.
Published: (2025-01-01)

The role of intestinal ultrasound with colour Doppler in predicting the response to biologic therapy in inflammatory bowel disease patients
by: Mohamed Ali El-Nady, et al.
Published: (2023-11-01)

Avolition Characterizes the Chronic Fatigue Experienced in Quiescent Inflammatory Bowel Disease
by: Tristan Gabriel-Segard, et al.
Published: (2025-01-01)

The Influence of Physical Activity on Inflammatory Markers, Intestinal Microbiota Composition and Disease Activity in Inflammatory Bowel Disease
by: Paulina Jakubczyk, et al.
Published: (2025-01-01)

Resveratrol and its derivates improve inflammatory bowel disease by targeting gut microbiota and inflammatory signaling pathways
by: Ming Li, et al.
Published: (2022-01-01)

Modern Approaches in the Morphological Diagnosis of Inflammatory Bowel Diseases
by: A. S. Tertychnyy, et al.
Published: (2022-08-01)

Biological markers of disease activity in inflammatory bowel diseases
by: Edyta Szymanska, et al.
Published: (2023-07-01)

The Mechanisms of Action of Interleukin-1 on Rabbit Intestinal Epithelial Cells
by: Fadia R. Homaidan, et al.
Published: (1999-01-01)

Retrospective Investigation of Cytomegalovirus and Epstein–Barr Virus Positivity in Inflammatory Bowel Disease Patient Biopsies
by: Hasan Bostancı, et al.
Published: (2024-01-01)

An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
by: Hongzhen Wu, et al.
Published: (2025-01-01)